QAD reports loss as $2B acquisition nears
QAD, a Santa Barbara-based cloud software company for the manufacturing industry, saw its revenue and expenses rise in the second quarter of 2021 as the company prepares to be bought out by a San Francisco-based private equity firm. QAD lost $6.3 million, or 31 cents per share, in the quarter ended July 31, the company Read More →
Teledyne Chairman Mehrabian will step back into CEO’s office
Teledyne Technologies Chairman Robert Mehrabian, who spent two decades as the company’s CEO, will step back into that post when Teledyne’s current CEO, Al Pichelli, retires on Oct. 15. Mehrabian is Pichelli’s predecessor as well as his successor — Pichelli took over as CEO on Jan. 1, 2019 when Mehrabian stepped down. Mehrabian was president Read More →
Arcutis starts new Phase 3 trial
Arcutis Biotherapeutics announced Aug. 25 that it has enrolled the first patient in a Phase 3 clinical trial to evaluate ARQ-154, its topical foam, as a treatment for scalp and body psoriasis. The foam is a once-daily formulation of roflumilast, a phosphodiesterase type 4 inhibitor that the company is developing to treat two skin conditions: Read More →
Limoneira predicts earnings growth despite drought and supply chain woes
Santa Paula-based agribusiness Limoneira released preliminary financial results on Aug. 24 for its most recent quarter, highlighting strong fresh lemon utilization which helped offset a smaller-than-expected avocado output. Limoneria said it expects revenue of $49 million in the third quarter of 2021, which would be a slight decrease from the same quarter a year ago, Read More →
Losses shrink at Cure Pharmaceutical
Cure Pharmaceutical Co., an Oxnard-based drug delivery product company that owns the CBD brand Sera Labs, reported rising revenue and shrinking losses for the quarter ended June 30. Cure’s net loss for the second quarter of 2021 was $1.3 million, down from a loss of $13.4 million in the same quarter of 2020. Total revenue Read More →
Glass House Brands reports Q2 loss, growing revenue as it plans expansion into Ventura County
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Revenue and losses both growing at MannKind
MannKind saw a significant rise in revenue thanks to its product Afrezza, but its net loss in the second quarter of fiscal year 2021 also rose significantly as the company tried to pay down its debt. The Westlake Village biotech company released its earnings after the markets closed on Aug. 11. It opened the next Read More →
